The CD73 ectonucleotidase catalyses the hydrolysis of AMP to adenosine, an immunosuppressive molecule. Recent evidence has demonstrated that this ectonucleotidase is up‐regulated in T helper type 17 cells when generated in the presence of transforming growth factor‐β (TGF‐β), and hence CD73 expression is related to the acquisition of immunosuppressive potential by these cells. TGF‐β is also able to induce CD73 expression in CD8⁺ T cells but the function of this ectonucleotidase in CD8⁺ T cells is still unknown. Here, we show that Tc17 cells present high levels of the CD73 ectonucleotidase and produce adenosine; however, they do not suppress the proliferation of CD4⁺ T cells. Interestingly, we report that adenosine signalling through A2A receptor favours interleukin‐17 production and the expression of stem cell‐associated transcription factors such as tcf‐7 and lef‐1 but restrains the acquisition of Tc1‐related effector molecules such as interferon‐γ and Granzyme B by Tc17 cells. Within the tumour microenvironment, CD73 is highly expressed in CD62L⁺ CD127⁺ CD8⁺ T cells (memory T cells) and is down‐regulated in GZMB⁺ KLRG1⁺ CD8⁺ T cells (terminally differentiated T cells), demonstrating that CD73 is expressed in memory/naive cells and is down‐regulated during differentiation. These data reveal a novel function of CD73 ectonucleotidase in arresting CD8⁺ T‐cell differentiation and support the idea that CD73‐driven adenosine production by Tc17 cells may promote stem cell‐like properties in Tc17 cells.